总时间（秒）：39.27
问答时间（秒）：36.79

<think>
Okay, let's start by reading through the provided literature. The main focus here is on the structural effects of Parkinson's disease-linked DJ-1 mutations. The authors used NMR and circular dichroism spectroscopy to evaluate five different mutations: L166P, E64D, M26I, A104T, and D149A.

First, I need to extract the genetic variants. The gene in question is DJ-1, which is also known as PARK7. The variants mentioned are L166P, E64D, M26I, A104T, and D149A. However, the literature doesn't provide the exact HGVS nomenclature, only the protein changes. Since the user requires HGVS standardization via API, but the paper doesn't mention transcript numbers or cDNA changes, I might have to use N.D. for those fields. But wait, the user example had a variant with cDNA and protein changes. However, in this case, the literature only gives amino acid changes. So, the HGVS nomenclature might not be available here, so I'll have to put N.D. for the transcript and cDNA details.

Next, the disease associated with these mutations is Parkinson's disease. I need to check MONDO for the correct term. MONDO:0005318 is Parkinson's disease. So that's the MONDO term.

Now, the experimental methods: the study used solution state NMR and circular dichroism spectroscopies. I need to structure this into the JSON format. The material used is the wild-type protein and the mutant proteins. The readout types would be structural perturbations and thermodynamic stability. The readout description should include all the variants mentioned. Each variant's effect is described: L166P causes severe destabilization, E64D is nearly unperturbed, others (M26I, A104T, D149A) have intermediate effects. The molecular effects would be loss-of-function for L166P, no effect for E64D, and intermediate for the others.

For biological and technical replicates, the paper doesn't mention them, so N.D. The controls: the positive control is the wild-type protein, and the negative control isn't explicitly mentioned, but since it's a comparison between wild-type and mutants, maybe the wild-type is the positive control and mutants as negative? Not sure. The validation controls for P/LP and B/LB aren't mentioned here, so N.D. for counts. Statistical analysis method isn't specified, so N.D. Thresholds for normal and abnormal readouts: the paper mentions structural changes and thermodynamic stability, but exact thresholds are not given. So I'll use custom thresholds based on standard practices, like normal being no significant change and abnormal being significant changes.

Approved assay: the methods used (NMR and CD) are standard for structural analysis, so likely approved.

Putting it all together into the JSON structure, making sure each field is filled as per the examples and the information from the paper.
</think>

{
  "Variants Include": [
    {
      "Gene": "PARK7",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "E64D"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "26"
          },
          "Description in input context": "M26I"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "104"
          },
          "Description in input context": "A104T"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "D",
            "alt": "A",
            "position": "149"
          },
          "Description in input context": "D149A"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005318"
  },
  "Experiment Method": [
    {
      "Assay Method": "Solution state NMR and Circular Dichroism Spectroscopy",
      "Material used": {
        "Material Source": "Protein samples (wild-type and mutants)",
        "Material Name": "DJ-1 (PARK7) protein variants",
        "Description": "Structural and thermodynamic analyses were performed on wild-type and mutant DJ-1 proteins."
      },
      "Readout type": "Structural and thermodynamic perturbations",
      "Readout description": [
        {
          "Variant": "L166P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "L166P caused severe destabilization and structural perturbations."
        },
        {
          "Variant": "E64D",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "E64D showed minimal structural or thermodynamic changes."
        },
        {
          "Variant": "M26I",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "M26I exhibited intermediate structural perturbations."
        },
        {
          "Variant": "A104T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "A104T showed intermediate structural and thermodynamic effects."
        },
        {
          "Variant": "D149A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "D149A caused intermediate structural and thermodynamic changes."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type DJ-1 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant structural or thermodynamic changes compared to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant structural or thermodynamic perturbations (e.g., >50% destabilization).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}